Navigation Links
Ceremed Awarded Third NIH Grant to Develop Soluble Hemostatic Carriers for Targeted Delivery of Therapeutic Agents to the Surgical Site
Date:10/4/2010

LOS ANGELES, Oct. 4 /PRNewswire/ -- Ceremed, Inc. was awarded a Small Business Innovation Research (SBIR) grant, the company's third in a series of grants from the National Institutes of Health to develop a versatile soluble carrier with bone hemostatic properties for targeted delivery of therapeutic agents directly to surgical sites. The recently awarded grant will aid Ceremed in its effort to develop a soluble carrier to topically deliver the antibiotic Vancomycin.

Topical delivery of therapeutics is a valuable tool in securing better patient outcomes, particularly in many common cardiac, orthopedic, spinal, and neurosurgical procedures. Ceremed's anhydrous, soluble, and highly malleable carrier is made of proprietary AOC® material. Applied to cut bone, the AOC® carrier will control bleeding and release therapeutic agents as it dissolves without compromising the healing process.

The AOC® formulation with Vancomycin, in combination with a carrier for the antibiotic Gentamicin, under development thanks to an earlier NIH grant, will target both susceptible and methycillin-resistant (MRSA) organisms to help prevent post operative infections, reduce the cost of potentially preventable complications, and improve patient outcomes across surgical fields. The third grant in the series was awarded for the development of an AOC® carrier for DBM. AOC® with DBM allows for stable delivery of bone growth factors directly to the bone, strengthens bone fusion, and promotes significantly earlier onset of healing and postoperative recovery without increased risk of complications.

"Utilizing the AOC® material for delivery of therapeutics has great potential to continue improving patient outcomes across surgical fields," said Ceremed's Chairman Tadeusz Wellisz, MD. "Ceremed has experienced success in developing soluble carriers for DBM and Gentamicin, and we look forward to continued success in the development of AOC® Vanco
'/>"/>

SOURCE Ceremed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
2. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
3. Twin City Pharmacy & Surgical Awarded NJHPCO 2010 Pharmacists of the Year
4. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
5. Microfluidic Systems (MFSI) is Awarded Four New Patents in the Field of Automated Biological Sample Processing and Detection.
6. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
7. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
8. Sysmex America Awarded National Novation GPO Contract for Automated Urinalysis
9. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
10. CRF Health is Awarded for Getting Closer
11. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 The North American dental lasers ... estimated to reach $90.7 million by 2019, at a CAGR ... the TOC of North America Dental Lasers Market for an ... various tables and figures. http://www.micromarketmonitor.com/market/north-america-dental-lasers-1771208223.html ... report.   Dental lasers are specifically used ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... of the results of the Company,s 72-patient, placebo-controlled ... drops) for the treatment of dry eye patients ... ) model.  The exploratory study was completed in ... disseminated by the Company in a press release, ...
(Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
Breaking Medicine Technology:North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Luitpold Pharmaceuticals, Inc. ("Luitpold") today announced that it ... drug products manufactured at its Shirley, New York ... subsidiary and Animal Health Division.  This action DOES ... subsidiary, including its Betamethasone Sodium Phosphate and Betamethasone ...
... April 21, 2011 / PRNewswire/ -- ... liquid potassium iodide product indicated for thyroid protection in ... the changes necessary to ramp up production to meet ... ThyroShield is an over-the-counter iodide solution which, when taken ...
Cached Medicine Technology:Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:5/22/2015)... May 22, 2015 River Valley Health ... Johnson, the health system’s Chief Financial Officer (CFO), will ... has served as the company CFO since 2011. , ... be joining the health system as CFO. Wesley will ... basis, while the Board of Trustees conducts a formal ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Hands ... that June 17, 2015, the Annual One Day Sale ... Since 2007, Hands On HCMT offers drastically reduced certificates one ... and estheticians have enough sessions, through what used to be ... is wonderful for the community as well. This once a ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning ... some tips to help promote safe travel. , According to ... traffic fatalities this Memorial Day weekend. Amica is sharing the ... Association: , , Always wear a ... seatbelt, whether they’re driving or riding along as a passenger. ...
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania ... totaling almost 2,500 confirmed drug deaths, as reported on May ... 2,489 deaths stemming from legal and illegal drug use in ... every day to fatal overdoses or other drug related deaths. ... of the most rife with drug related deaths. The city, ...
(Date:5/22/2015)... VA (PRWEB) May 22, 2015 ... presented at the American Society of Clinical Oncology ... demonstrated improved survival rates for those patients who ... chemotherapy regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) ... growth), and it is already routinely used to ...
Breaking Medicine News(10 mins):Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... finds , , FRIDAY, Oct. 31 (HealthDay News) -- The more weight ... have a large baby, posing health risks to both mother and ... than 40 pounds -- the maximum recommended pregnancy weight gain -- ... 9 pounds, the researchers said. , An estimated one-fifth of women ...
... amino acid glycine has been shown to be anti-inflammatory ... dietary glycine protected both the lung and liver against ... and improved graft survival after liver transplantation. The influence ... was not known. , A research article to be ...
... TACE has been widely accepted as a choice of ... and reproducible technique for assessing perfusion changes due to ... few reports on the application of this technique in ... of perfusion parameters. , A research article published on ...
... to sign up online at http://www.diabetesatlanta.org , ATLANTA, ... than 600,000 Georgians, could be present in more than,300,000 more, ... disease?, No. The answer is diabetes., And, new ... the U.S. has,nearly doubled in the past 10 years - ...
... organ donation - where people have to opt out of donating ... tackle a growing waiting list for transplant. , That is the ... the illegal trade of body parts, who has recently joined the ... more than 7,500 patients in the UK currently on the waiting ...
... InStil Health,Insurance Co., a leading provider of Medicare ... South Carolina and Georgia, announced today,that longtime insurance ... operating officer of the company., Hart has ... insurance industry,and extensive knowledge of the Medicare program. ...
Cached Medicine News:Health News:Excess Weight Gain During Pregnancy a Risk to Mother and Child 2Health News:As Diabetes Reaches Epidemic Levels in Georgia and U.S., Thousands Drawn to Diabetes University in Atlanta Nov. 8 2Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Jim Hart Named President, COO of InStil Health Insurance Co. 2
... Field Lens combines exceptional wide ... The enhanced double aspheric design ... resolution stereo views of the ... unique features make it ideal ...
... Stereo Fundus Lens is specifically designed for ... retina. Its enhanced 3-D stereoscopic design enables ... detail, making it ideal for detecting changes ... serous detachments and other macular abnormalities. It ...
The Pan Retinal® 2.2 uniquely combines magnification nearly that of the 20D lens with a field of view approaching that of the 30D lens. Excellent for virtually every examination procedure, includ...
... Volks state-of-the-art 20D diagnostic/laser lens is ... aberrations and coma delivering the ... diopter lens on the market. Its ... linear image magnification and perfect image ...
Medicine Products: